The Italian version of this article was first published on Diritto 24 - Il Sole 24 Ore. The health emergency due to the spread of COVID-19 has made the need to correctly manage the processing of health data for scientific research purposes even more topical.
By means of Law Decree No. 34 of May 19, 2020, known as the “Decreto Rilancio” (the “19 May Decree”), and the new provisions on health and safety protocol (the “H&S Protocol”) executed on April 24, 2020, new measures have been put in place that deal with the reopening phase (commonly known as Phase 2) and the effects of the lockdown on business over the next few months.
The Italian version of this article was first published on Wired.
As partial lockdowns across Europe are extended, the coronavirus outbreak is generating an acceleration in the “going to digital” processes of companies across different sectors. E-commerce, more than others, is experiencing such acceleration.
The coronavirus emergency has forced companies to face an array of unprecedented challenges, among them the requirements that ensure compliance with Legislative Decree No. 231/2001, which introduced corporate criminal liability in Italian legislation.